Cell therapy downstream processing and analytics

CELL AND GENE THERAPY INSIGHTS

November 2024

Cell therapy downstream processing and analytics

Download PDF

Expert Insight

Interpreting the new FDA draft potency guidance: an mRNA gene modified cell therapy perspective

Interpreting the new FDA draft potency guidance: an mRNA gene modified cell therapy perspective

Damian Marshall, Kayleigh Thirlwell

Review

Phase-appropriate analytical control of cell therapy manufacture in early development stages

Phase-appropriate analytical control of cell therapy manufacture in early development stages

FastFacts

Novel isolation platform with active-release technology for scalable cell therapy manufacturing

Novel isolation platform with active-release technology for scalable cell therapy manufacturing

Moen Ingrid Nyhus

Infographic

Cell therapy analytics: INFOGRAPHIC

Cell therapy analytics: INFOGRAPHIC

Interview

Pioneering quality control in biomanufacturing of cell and gene therapies

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez

Troubleshooting process and analytical tool changes in an approved ATMP process

Troubleshooting process and analytical tool changes in an approved ATMP process

Maitane Ortiz, Marta Malo De Molina

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Webinars

Enhancing CAR-T therapy development: harnessing cell selection flexibility

Enhancing CAR-T therapy development: harnessing cell selection flexibility

Tamara Laskowski, Nuala Trainor

Optimizing for the future: streamlining the production of T cell-based immunotherapies

Optimizing for the future: streamlining the production of T cell-based immunotherapies

Paula Lam, Soong Poh Loong